Evolent Health, Inc.

NYSE:EVH 주식 보고서

시가총액: US$3.4b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Evolent Health 과거 수익 실적

과거 기준 확인 0/6

Evolent Health은 연평균 28.1%의 비율로 수입이 증가해 온 반면, Healthcare Services 산업은 연평균 8.3%의 비율로 수입이 증가했습니다. 매출은 연평균 22.1%의 비율로 증가했습니다.

주요 정보

32.1%

수익 성장률

38.1%

EPS 성장률

Healthcare Services 산업 성장1.7%
매출 성장률23.7%
자기자본 수익률-6.0%
순이익-4.5%
최근 수익 업데이트30 Jun 2024

최근 과거 실적 업데이트

Recent updates

Evolent Health (NYSE:EVH) Has A Pretty Healthy Balance Sheet

Sep 19
Evolent Health (NYSE:EVH) Has A Pretty Healthy Balance Sheet

Evolent Health: Let The Bidding Begin

Aug 23

Potential Upside For Evolent Health, Inc. (NYSE:EVH) Not Without Risk

Jul 29
Potential Upside For Evolent Health, Inc. (NYSE:EVH) Not Without Risk

Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher

Jul 01
Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher

Evolent Health: Recent Pullback, A Buying Opportunity Or Not? (Rating Downgrade)

May 22

These 4 Measures Indicate That Evolent Health (NYSE:EVH) Is Using Debt Reasonably Well

May 05
These 4 Measures Indicate That Evolent Health (NYSE:EVH) Is Using Debt Reasonably Well

Evolent Health, Inc. (NYSE:EVH) Doing What It Can To Lift Shares

Apr 08
Evolent Health, Inc. (NYSE:EVH) Doing What It Can To Lift Shares

Evolent Health (NYSE:EVH) Is Experiencing Growth In Returns On Capital

Mar 12
Evolent Health (NYSE:EVH) Is Experiencing Growth In Returns On Capital

Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

Jan 17
Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

Many Still Looking Away From Evolent Health, Inc. (NYSE:EVH)

Dec 21
Many Still Looking Away From Evolent Health, Inc. (NYSE:EVH)

Evolent Health (NYSE:EVH) Is Looking To Continue Growing Its Returns On Capital

Nov 30
Evolent Health (NYSE:EVH) Is Looking To Continue Growing Its Returns On Capital

A First Evaluation On Evolent Health

Oct 04

Does Evolent Health (NYSE:EVH) Have A Healthy Balance Sheet?

Sep 29
Does Evolent Health (NYSE:EVH) Have A Healthy Balance Sheet?

There's Been No Shortage Of Growth Recently For Evolent Health's (NYSE:EVH) Returns On Capital

Sep 01
There's Been No Shortage Of Growth Recently For Evolent Health's (NYSE:EVH) Returns On Capital

An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 47% Undervalued

Aug 04
An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 47% Undervalued

Evolent Health: Business Economics Still Appealing, Reiterate Buy

Jul 19

Cautious Investors Not Rewarding Evolent Health, Inc.'s (NYSE:EVH) Performance Completely

Jun 14
Cautious Investors Not Rewarding Evolent Health, Inc.'s (NYSE:EVH) Performance Completely

Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

May 30
Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 34% Undervalued

May 02
An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 34% Undervalued

Evolent Health (NYSE:EVH) Shareholders Will Want The ROCE Trajectory To Continue

Apr 17
Evolent Health (NYSE:EVH) Shareholders Will Want The ROCE Trajectory To Continue

Evolent Health GAAP EPS of $0.11 beats by $0.13, revenue of $382.4M beats by $9.47M

Feb 22

Is Evolent Health (NYSE:EVH) A Risky Investment?

Feb 19
Is Evolent Health (NYSE:EVH) A Risky Investment?

Evolent Health: Strengthening Fundamentals, Investing At High Rates Of Return

Feb 15

Is Evolent Health, Inc. (NYSE:EVH) Potentially Undervalued?

Feb 01
Is Evolent Health, Inc. (NYSE:EVH) Potentially Undervalued?

Evolent Health (NYSE:EVH) Might Have The Makings Of A Multi-Bagger

Jan 14
Evolent Health (NYSE:EVH) Might Have The Makings Of A Multi-Bagger

Evolent spikes as Humana partnership expands

Jan 12

Is Evolent Health, Inc. (NYSE:EVH) Trading At A 49% Discount?

Dec 27
Is Evolent Health, Inc. (NYSE:EVH) Trading At A 49% Discount?

Evolent Health offered $23.5M class action securities settlement

Sep 19

Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher

Sep 18
Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher

Evolent Health: Improving Financials, But There's More

Aug 31

수익 및 비용 분석

Evolent Health 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.


수익 및 매출 내역

NYSE:EVH 수익, 비용 및 수입 (USD Millions )
날짜수익수익G+A 비용R&D 비용
30 Jun 242,354-1062750
31 Mar 242,176-1412980
31 Dec 231,964-1423060
30 Sep 231,790-1123200
30 Jun 231,632-772980
31 Mar 231,483-402630
31 Dec 221,352-192440
30 Sep 221,218-42430
30 Jun 221,088-192290
31 Mar 22990-242150
31 Dec 21908-302080
30 Sep 21906-451990
30 Jun 21923-681990
31 Mar 21918-2611970
31 Dec 20925-3281980
30 Sep 20915-5151960
30 Jun 20895-5042070
31 Mar 20870-3342280
31 Dec 19687-3042080
30 Sep 19803-1212480
30 Jun 19733-1072470
31 Mar 19685-862410
31 Dec 18627-532310
30 Sep 18548-492200
30 Jun 18506-492060
31 Mar 18468-561990
31 Dec 17435-611950
30 Sep 17409-651910
30 Jun 17362-641800
31 Mar 17311-551630
31 Dec 16254-1601480
30 Sep 16212-1461310
30 Jun 16192-1471220
31 Mar 161462201030
31 Dec 1597330710
30 Sep 1551322380
30 Jun 1510329130
31 Mar 150-37-10
31 Dec 140-3100
30 Sep 1413-2970
31 Dec 13262160

양질의 수익: EVH 은(는) 현재 수익성이 없습니다.

이익 마진 증가: EVH 은(는) 현재 수익성이 없습니다.


잉여현금흐름 대 수익 분석


과거 수익 성장 분석

수익추이: EVH 은(는) 수익성이 없지만 지난 5년 동안 연간 28.1% 의 비율로 손실을 줄였습니다.

성장 가속화: 현재 수익성이 없기 때문에 EVH 의 지난 1년 동안의 수익 성장을 5년 평균과 비교할 수 없습니다.

수익 대 산업: EVH 은(는) 수익성이 없어 지난 해 수익 성장을 Healthcare Services 업계( 8.6% )와 비교하기 어렵습니다.


자기자본 수익률

높은 ROE: EVH 현재 수익성이 없기 때문에 마이너스 자본 수익률( -8.98% )을 갖습니다.


자산 수익률


고용 자본 수익률


과거 성과가 우수한 기업 찾기